- Tytuł:
- Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study
- Autorzy:
- Źródło:
- In The Lancet Infectious Diseases August 2017 17(8):854-866
Czasopismo naukowe